Skip to content

Study on the effect of timing of transcatheter arterial embolization on the prognosis of patients with severe pelvic fractures

Study on the effect of timing of transcatheter arterial embolization on the prognosis of patients with severe pelvic fractures

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500109159
Enrollment
Unknown
Registered
2025-09-12
Start date
2023-03-16
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic fracture

Interventions

control group:Adopting the conventional pelvic fracture treatment process, establishing venous access, providing fluid resuscitation and blood transfusion to the patient, performing pelvic fixation, e
intervention group:Incorporate time target management, develop a "Green Channel Time Node Record Form for Severe Pelvic Fracture Patients", and strictly control various important time nodes during the

Sponsors

The Second Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age range: 18-80 years old; 2. Pelvic CT confirms the diagnostic criteria for traumatic pelvic fractures or the presence of hemodynamic instability; 3. Pelvic fractures require TAE treatment; 4. Voluntary participation in this study and sign a written informed consent form;

Exclusion criteria

Exclusion criteria: 1. Trauma with chronic cardiopulmonary insufficiency, severe infectious diseases, chronic renal insufficiency or malignant tumor; 2. Individuals who have recently received anticoagulant therapy due to illness, which affects their coagulation function; 3. Out of hospital cardiac arrest (OHCA) without resuscitation response, died in the emergency room; 4. Receive TAE treatment after treating other injuries (such as thoracotomy, laparotomy, delayed bleeding during ICU observation) 5. Trauma accompanied by hypothyroidism or adrenal insufficiency. 6. Study exit criteria: During the trial period, the patient withdrew (actively/passively).

Design outcomes

Primary

MeasureTime frame
ime from admission to DSA treatment;The length of stay (LOS) in the intensive care unit (ICU);TAE waiting time<2 hours compliance rate;

Secondary

MeasureTime frame
Patient Injury Severity Score (ISS);Preoperative and postoperative shock index (using Mindray ECG monitor uniformly);

Countries

China

Contacts

Public ContactLeilei Yan

The Second Affiliated Hospital of Wenzhou Medical University

108600886@qq.com+86 135 6612 1846

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026